CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO - Portugal 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:500-600
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:37
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 24
As coordinator: 3
As participant: 8
Sole participant: 13
Coordinator / Participant Ratio: 0.38*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 159.815 0 159.815 1
2021 2.647.815 0 2.647.815 2
2020 307.630 11.773.000 937.630 2 1
2019 4.032.949 0 860.976 2
2018 148.636 3.590.355 863.705 1 1
2017 3.817.331 3.750.899 1.208.561 3 1
2016 148.636 8.808.363 556.226 1 1
2015 202.630 0 202.630 1
2013 100.000 0 100.000 1
2012 0 5.011.843 2.000.458 2
2011 0 7.510.071 683.069 2
2010 247.284 0 247.284 2

Networking:

Partners:

Institution:Projects [No]:
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS4
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT3
KAROLINSKA INSTITUTE3
ASSOCIACAO PROTECTORA DOS DIABETICOS DE PORTUGAL2
CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA EPE2
CONSIGLIO NAZIONALE DELLE RICERCHE2
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
INSTYTUT BIOLOGII DOSWIADCZALNEJ IM M NENCKIEGO POLSKIEJ AKADEMII NAUK2
KING'S COLLEGE LONDON2
MEDIAGNOST GESELLSCHAFT FUR FORSCHUNG UND HERSTELLUNG VON DIAGNOSTIKA2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
STIFTELSEN SINTEF2
UNIVERSIDADE DO PORTO2
UNIVERSITA DEGLI STUDI DI BARI ALDO MORO2
UNIVERSITAET INNSBRUCK2
AC IMMUNE1
ANAXOMICS BIOTECH S L1
ASPHALION SL1
ASTELLAS PHARMA EUROPE BV1
BAYER1
BIOILIBERIS RESEARCH AND DEVELOPMENT SL1
BNML BEHAVIORAL & MOLECULAR LAB1
BRAINS FOR BRAIN FOUNDATION ONLUS1
CARL ZEISS1
CELL STRESS DISCOVERIES LIMITED1
CETICS1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED MP1
CRANFIELD UNIVERSITY1
DROPTECH1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ENKAM PHARMACEUTICALS1
EUROTRIALS SCIENTIFIC CONSULTANTS1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO LA PRINCESA1
FYZIOLOGICKY USTAV AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE1
GENETHON1
GENOSAFE SAS1
H LUNDBECK1
H LUNDBECK AS1
HCS PHARMA1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSTITUT CURIE1
INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE1
INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE TOULOUSE INSAT1
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA1
JANSSEN PHARMACEUTICA NV1
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT1
LONZA1
LUND UNIVERSITY1
LUNDS UNIVERSITET1
LYSOGENE1
MARIONETASSOCIACAO CULTURAL1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MEDIMMUNE LIMITED1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MICROBIOLYTICS1
MIMETAS BV1
MJR PHARMJET1
MYBIOTECH1
NIMGENETICS GENOMICA Y MEDICINA SL1
NORGES TEKNISKNATURVITENSKAPELIGE UNIVERSITET NTNU1
NOVARTIS PHARMA1
NOVO NORDISK1
NOVOZYMES1
NSGENE1
OROBOROS INSTRUMENTS1
OULUN YLIOPISTO1
PFIZER LIMITED1
PHARMACOIDEA FEJLESZTO ES SZOLGALTATO KFT1
PIN PROGRESSO INFANTIL1
PROZOMIX LIMITED1
QIAGEN AARHUS AS1
SANOFIAVENTIS1
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT1
SEAHORSE BIOSCIENCE EUROPE APS1
SIENA BIOTECH1
SPARK THERAPEUTICS INC1
SYNVACCINE1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
TAKIS1
TECHNION ISRAEL INSTITUTE OF TECHNOLOGY1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE1
THE HEBREW UNIVERSITY OF JERUSALEM1
THE ROSALIND FRANKLIN INSTITUTE1
THE UNIVERSITY OF EDINBURGH1
THE UNIVERSITY OF LIVERPOOL1
THE UNIVERSITY OF SHEFFIELD1
THE UNIVERSITY OF WARWICK1
UNIVERSIDAD AUTONOMA DE MADRID1
UNIVERSIDAD DE ALICANTE1
UNIVERSIDAD DE LLEIDA1
UNIVERSIDADE DE COIMBRA1
UNIVERSITAET DES SAARLANDES1
UNIVERSITAETSKLINIKUM HEIDELBERG1
UNIVERSITE CATHOLIQUE DE LOUVAIN1

Constancy:

Total number of partners: 137
Partner loyalty:
Frequent Partner: (> 2 projects): 13
Rare Partner: 124
Frequent / Rare Partner Ratio: 0.1

Project overview:

Start dateProjectacronymrolefundingpartners
2022-05-01Design and development of exosomes with brush type architecture as RNA delivery vectors for active targeting of blood brain barrier (BBB) ExoBBBcoordinator159.8151
2021-09-01Exploring the dendritic molecular machinery responsible for neuronal polarization SortAxcoordinator147.8151
2021-01-01DYNAMIC BRAIN FUNCTION: Towards the Understanding and Treatment of Brain Disorders DYNABraincoordinator2.500.0001
2020-11-01Accelerating Research & Development for Advanced Therapies ARDATparticipant11.773.00034
2020-10-15Functional high-throughput analysis of the role of microRNAs in regulating Staphylococcus aureus infection miRs4Staphcoordinator147.8151
2020-05-01LIght-responsive GrapHene-based inTerfaces for Electrical STimulation LIGHTESTcoordinator159.8151
2019-07-01Improving drug delivery to the brain and glioblastoma treatment using temperature. Nano_Braincoordinator147.8151
2019-03-01Synaptic Dysfunction in Neuropsychiatric Disorders Syn2Psycoordinator3.885.13411
2018-06-01New nanomaterials for neural stem cells drug delivery NANOSTEMparticipant3.590.35514
2018-05-07Production and Testing of humAn-derived Neurons and brain organoids: advanced model probing in neurodevelopmental disorders ProTeANcoordinator148.6361
2017-06-01mitoFOIE GRAS: Non-invasive Profiling of Mitochondrial Function in Non-Alcoholic Fatty Liver Disease mtFOIE GRAScoordinator454.50013
2017-04-01Therapy for regeneration of Heart Muscle based on targeted delivery of exosomes TRoMBONEcoordinator160.6361
2017-01-01Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease Foie Grascoordinator3.202.19614
2017-01-01Training European Network: Metabolic Dysfunctions associated with Pharmacological Treatment of Schizophrenia TREATMENTparticipant3.750.89912
2016-06-01Advanced toolbox for rapid and cost-effective functional metagenomic screening - microbiology meets microfluidics. METAFLUIDICSparticipant8.808.36314
2016-03-01Functional high-throughput analysis of the role of microRNAs in cardiac ischemia-reperfusion injury microCardiocoordinator148.6361
2015-02-18Mechanisms underlying hemogenic induction in human fibrobalsts Inducing Hemogenesiscoordinator202.6301
2013-08-01CELLULAR AND SYNAPTIC DISSECTION OF THE NEURONAL CIRCUITS OF SOCIAL AND AUTISTIC BEHAVIOR CELLSYNCIRCUITScoordinator100.0001
2012-11-01Triggerable nanomaterials to modulate cell activity NANOTRIGGERparticipant1.699.3201
2012-10-01Cancer Associated Fibroblasts (CAF) Function in Tumor Expansion and Invasion CAFFEINparticipant3.312.52311
2011-11-01Novel nanoparticles for drug delivery to the skin NANODRUGparticipant3.752.7538
2011-03-01TreatPolyQ – Industrial Academic Initial Training Network towards treatment of Polyglutamine Diseases TreatPolyQparticipant3.757.31816
2010-08-01Role of Mitochondrial Physiology in Tumor Stem Cell Resistance to Chemotherapeutics MitoCancerStemcoordinator147.2841
2010-04-01The role of local mRNA translation in synapse formation Presynaptogenesiscoordinator100.0001

Alias institution names:

  • CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO